Item 5.07 - Submission of Matters to a Vote of Security Holders.

The 2022 Annual Meeting of Stockholders (the "Annual Meeting") of Sesen Bio, Inc. (the "Company") was held on June 22, 2022. Stockholders voted on the matters set forth below:

a) Each of the following nominees was elected to the Company's Board of Directors (the "Board") as a class II director, for a three-year term ending at the annual meeting of stockholders to be held in 2025 and until his respective successor has been duly elected and qualified, and received the number of votes as follows:



        Name             Votes For        Withheld        Broker Non-Votes
 Jay S. Duker, M.D.      46,200,353      29,617,231          43,066,094
   Jason A. Keyes        54,574,256      21,243,328          43,066,094

b) The proposal to ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022 was approved based on the following number of votes:



  Votes For        Votes Against       Abstentions        Broker Non-Votes
 109,100,482         6,776,842          3,006,353                0

c) The proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 28, 2022 was approved based on the following number of votes:



 Votes For        Votes Against       Abstentions        Broker Non-Votes
 50,675,949        21,321,610          3,820,024            43,066,094

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses